Abbonarsi

Factors associated with physicians’ recommendations for managing low-risk papillary thyroid cancer - 15/06/21

Doi : 10.1016/j.amjsurg.2020.11.021 
Alexandria D. McDow a, , Benjamin R. Roman b , Megan C. Saucke c , Catherine B. Jensen c , Nick Zaborek d , Jamia Linn Jennings e , Louise Davies f , Juan P. Brito g , Susan C. Pitt c
a Division of Surgery Oncology, Department of Surgery, Indiana University School of Medicine, 545 Barnhill Drive EH 537, Indianapolis, IN, 46202, USA 
b Division of Head and Neck, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA 
c Department of Surgery, University of Wisconsin School of Medicine and Public Health, 600 Highland Ave., Madison, WI, 53792, USA 
d Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, 600 Highland Ave., Madison, WI, 53792, USA 
e Wisconsin Department of Health Services, 1 West Wilson Street, Madison, WI, 53703, USA 
f The VA Outcomes Group, Department of Veterans Affairs Medical Center, White River Junction, VT, USA and The Dartmouth Institute for Health Policy and Clinical Practice, Hanover, NH, 1 Medical Center Drive, Lebanon, NH, 03756, USA 
g Division of Diabetes, Endocrinology, Metabolism, and Nutrition, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA 

Corresponding author. Indiana University School of Medicine, Department of Surgery - Division of Surgical Oncology, 545 Barnhill Drive EH 537, Indianapolis, IN, 46202, USA.Indiana University School of MedicineDepartment of Surgery - Division of Surgical Oncology545 Barnhill Drive EH 537IndianapolisIN46202USA

Abstract

Background

The 2015 American Thyroid Association endorsed less aggressive management for low-risk papillary thyroid cancer (LR-PTC). We aimed to identify factors influencing physicians’ recommendations for LR-PTC.

Methods

We surveyed members of three professional societies and assessed respondents’ recommendations for managing LR-PTC using patient scenarios. Multivariable logistic regression models identified clinical and non-clinical factors associated with recommending total thyroidectomy (TT) and active surveillance (AS).

Results

The 345 respondents included 246 surgeons and 99 endocrinologists. Physicians’ preference for their own management if diagnosed with LR-PTC had the strongest association with their recommendation for TT and AS (TT: OR 12.3; AS: OR 7.5, p < 0.001). Physician specialty and stated patient preference were also significantly associated with their recommendations for both management options. Respondents who received information about AS had increased odds of recommending AS.

Conclusions

Physicians’ recommendations for LR-PTC are strongly influenced by non-clinical factors, such as personal treatment preference and specialty.

Il testo completo di questo articolo è disponibile in PDF.

Highlights

Physician recommendations for low-risk papillary thyroid cancer are multifactorial.
Physicians’ personal treatment preference is associated with their recommendations.
Physician specialty and stated patient preference also influence recommendations.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Thyroid cancer, Overtreatment, Low-risk, Active surveillance, Survey, Thyroidectomy


Mappa


© 2021  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 222 - N° 1

P. 111-118 - luglio 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • A longitudinal cadaver-based simulation curriculum creates sustainable increases in resident confidence and exposure to fundamental techniques: Results of a 5-year program evaluation
  • Brendan P. Lovasik, Steven C. Kim, Vivian L. Wang, Katherine T. Fay, Matthew T. Santore, Keith A. Delman, Jahnavi K. Srinivasan
| Articolo seguente Articolo seguente
  • Analysis of adjuvant chemotherapy in patients undergoing curative-intent resection of localized adrenocortical carcinoma
  • Ali Al Asadi, Daniel M. Hubbs, Patrick J. Sweigert, Marshall S. Baker, Adam S. Kabaker

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.